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 Box S1 | Bioelectronic medicines: the detailed research roadmap  
 





Create organ-centric wiring diagrams in models representative of human anatomy.   
 
Research imperatives: 
• Generate tools for high-resolution tracing of the fibre anatomy and taxonomy to and 
from individual organs 
o Build a library of tracers to visualize the full length of pre-ganglionic axons, 
ganglionic cell bodies, post-ganglionic axons, and intrinsic neurons1, with 
particular focus on tracing that starts at the target organ2-5  
o Advance approaches for high-resolution labelling of peripheral 
neurotransmitters, their receptors and co-receptors, and for imaging of 
myelination, peri- and epineurium 
o Develop and adapt micrometer-resolution imaging and 3D reconstruction 
techniques for visceral organs and peripheral nerves (for example, 
automated tissue slicing, clearing, in situ hybridization, multi-photon 
imaging)6-12 
• Explore inter- and intra-species variation in neuroanatomy and establish the optimal 
animal models for detailed mapping of each organ 
o Update and extend the macro-level innervation map of the major visceral 
organs in key animal model species and establish the extent to which this 
map is conserved in humans  
o Characterise the variability in different parts of these maps between 
individuals 
• Build organ-centric high-resolution maps for each visceral organ in their most 
representative animal model 
o Conduct high-resolution nerve tracing, labelling, and imaging in the animal 
model of choice, taking the organ as the starting point 
o Standardise and coordinate mapping, data management and 3D visualisation 
across organs 
• Establish methods to image and find nerves in the clinical setting 
o Develop tracers and associated imaging techniques that can be used in 
human preoperative and intra-operative settings to identify and localize 
peripheral nerves  







Map the neural signalling patterns that control individual organ functions. 
 
Research imperatives: 
• Generate simultaneous recordings of neural signal pattern and organ function  
o Record both afferent (sensory) and efferent (motor) neural signals and 
associated end-organ biomarkers at a range of physiological stimuli    
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o Combine compound action potential recording from whole nerves and action 
potential recordings to better sample the signal patterns that may drive organ 
function13 
o Record these data sets in disease models where neural signalling may be 
implicated 
• Establish correlation and causation between neural signal patterns and individual 
organ functions 
o Establish correlations between spatial and temporal patterns in neural signals 
and the organ function, leveraging approaches from adaptive neural signal 
decoding13,14 
o Use stimulation and blocking experiments to test whether the identified 
patterns are necessary and sufficient to control the organ function 
o Investigate molecular, cellular, and physiological mechanisms by which 
efferent signals translate into changes of organ function and afferent signals 
arise from changes in organ function 
• Iterate as resolution and quality of interfacing technology increase until functional 
units are determined 
o Use increasing channel count, fibre- and action potential-level recordings, 
and implanted chronic recording platforms to improve correlations between 
neural signal patterns and organ functions15 
o Establish the degree of redundancy in parallel neural signals and the 
functional units of fibres; that is, the fibres that convey the same signals 
controlling the same organ function16 
• Build data recording standards and central repositories that allow collaborative data 
mining and re-analysis (analogous to the Allen Brain Atlas17,18) 
o Develop a standardised online database of visceral nerve activity across 
organs, species and disease models 
o Provide central tools for signal extraction, annotation and online analysis 
o Enable mining across organs to determine whether and where neural codes 
are conserved 
 
Advancement of interface technology 
	  
Electrodes for visceral nerves  
 
Overall objective: 
Adapt and advance electrode-based interfaces towards reliable visceral nerve signal 
recording and modulation19. 
 
Research imperatives: 
• Miniaturise interfaces for use on small nerves adjacent to organs to enable work in 
rodent disease models 
o Develop cuffs that optimally interface with nerves at <100µm diameter, 
recognising the signal-to-noise and charge injection issues associated with 
recording and stimulation using micron-scale electrode geometries20-26 
o Develop high-density arrays with micro-scale features and integrated active 
electronics which allow stable electrical interfacing with 10-100 channels in 
small nerves, while minimising axonal damage from displacement27-30    
• Adapt interface materials and architectures to meet the specific needs of the visceral 
neuroanatomy 
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o Develop in situ shape-adaptable interfaces that provide intimate contact to 
maximise signal-to-noise and reliable contact with small diameter nerves, 
irregular plexi, and ganglia embedded in adipose tissue and ligaments or 
covering organs and vessels  
o Explore approaches that allow reliable interfacing with the same nerve fibres 
over time32   
• Tailor electrode interfaces to determine the electrical impulse patterns and functional 
units for each organ  
o Establish if interfaces at near-organ branches provide greater specificity than 
high-channel arrays on a proximal nerve trunk when isolating electrical units 
controlling organ functions   
o Apply flexible substrates and signal analysis approaches to minimize motion 
artefacts from pulsating vasculature and movement of cardiac, diaphragm, 
intestinal, and somatic muscles13,33,34   
o Establish optimal de-coding strategies for action potentials with low signal-to-
noise, including optimising the spike detection and sorting algorithms for 
unmyelinated fibres13,35-37   
o Develop algorithms for tracking correlated activity over time across multiple 
fascicles or nerves14,38  
 
	  
Signal imaging and actuation 
 
Overall objective: 




• Scale electromagnetic reading, writing and blocking of action potentials to highly-
parallel nerve fibres  
o Extend the optogenetic toolbox to the periphery with the aim of imaging a 
population of individual action potentials and introducing or inhibiting 
distributed naturalistic signalling patterns39-41 
o Establish the in vivo reliability, temporal and spatial resolution of micro- and 
nano-particle reporters and actuators that can be remotely interrogated by 
optical or electromagnetic imaging approaches (for example, nano-dots, 
nano-diamonds, magnetic- and piezo-electric particles (“neural dust”))41-44 
o Develop methods for delivery, expression, and, distribution of nano-particle 
and genetically-encoded reporters into peripheral nerve fibres45,46  
o Explore virus serotypes, sub-cellular targeting motifs26 and self-
complementary viral vectors for axonal expression  
o Augment imaging techniques to detect action potentials through the highly 
scattering protective sheaths and membranes, with extended depths of field 
for simultaneous interrogation of fibre activity through the nerve bundle47 
• Develop less invasive approaches for recording and modulation of action potentials   
o Extend tomography techniques of various sensing modalities to derive neural 
signalling patterns 
o Develop ultrasonic and electromagnetic techniques for direct actuation of 
neural signals in targeted fibre bundles, and radio frequency for signal 
blocking48-50 
o Apply current-steering and field-shaping techniques for precision activation of 
fibres within 100µm nerves43,51 
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• Move successful technologies towards in vivo application 
o Miniaturise and reduce power of electromagnetic sources, waveguides and 
interfaces for implantable probes   
o Address the biocompatibility and biostability challenges associated with new 
technology, including pathological immune and neural responses52-54   
	  
	  
Sensing of organ functions 
 
Overall objective: 




• Define the physiological timescales and dynamic ranges for the markers of organ 
function  
o Determine the rate and dynamic range through sampling during physiological 
perturbations 
o Confirm change in surrogate markers through neurostimulation or blocking 
experiments  
• Advance non-invasive imaging and micro sampling techniques to support functional 
mapping 
o Develop imaging tracers for neurally-controlled metabolic and endocrine 
molecules  
o Establish procedures for micro sampling and time-stamped quantification at 
the arteries and veins of key organs such as the kidney, liver, pancreas, 
spleen and adrenal gland 
o Explore fluorescent and electrochemical approaches for high temporal and 
spatial resolution imaging to sense acetylcholine and norepinephrine 
release55-57 
• Develop in vivo sensors for markers required to close the loop in future bioelectronic 
medicines 
o Design microscopic, chip-based sensors for monitoring select molecular or 
physiological markers (for example, blood and airway pressure)  
o Advance long-term sensor reliability during exposure to body fluids with 
limited biofouling and need for re-calibration over time 
	  
	  
Visceral control modules 
 
Overall objective: 
Integrate neural interface and power management, signal processing, and data transfer in 
miniaturised platforms  
 
Research imperatives: 
• Develop a research platform that enables chronic neural recording, stimulation and 
blocking experiments 
o Design wireless, implantable modules that, combined with different neural 
interfaces, will enable characterisation of functionally specific neural signals 
to individual organs58 
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o Prove functionality for a small set of well-characterised organs, and then 
make the platform broadly available for circuit mapping and exploration of 
therapeutic hypotheses across visceral organs 
o Develop electronics platforms for control  of different neural interface 
modalities (for example, electrical stimulation, recording and blocking versus 
optical activation and inhibition) 
• Pursue miniaturisation to enable work in key animal models and pave the way for 
bioelectronic medicines 
o Enable functional mapping and therapeutic feasibility testing in rodent models 
of chronic diseases  
o Create the building blocks of future microscopic bioelectronic medicines 
compatible with keyhole surgery and associated broader patient reach 
• Increase local signal processing as pattern features are established and interface 
channel counts increase 
o Initially stream raw neural data from implantable modules to allow 
unconstrained downstream signal analysis 
o Use identified neural pattern features to inform low-power signal processing 




Early establishment of therapeutic feasibility 
 
Proof of principle 
 
Overall objective: 
Define which visceral neural circuits exert influence over disease progression in 
representative animal models. 
 
Research imperatives: 
• Leverage the rich body of rodent disease models for rapid proof of effect, provided 
the target circuit bears resemblance to human innervation 
o Use rats where feasible from a disease model point of view as this has higher 
feasibility and simpler scalability in terms of neural interface dimensions, 
instrumentation and surgical robustness as compared to mice 
o Utilise disease models representative of the organ pathophysiology (as 
opposed to only cellular or molecular pathophysiology)59,60 
o Revisit the validity of a rodent-derived proof of principle as data emerge on 
innervation and signal pattern variability between species 
• Record neuronal and biomarker patterns to identify functional relationships during 
disease progression  
o Record chronic time series in individual animals during disease onset and 
progression  
o Use implantable, wireless platforms for less variability than repeat terminal 
measures, no confounding of neural signals by anaesthesia, lower animal 
use, and improved animal welfare 
o Conduct correlation and causation analyses with control for drift in the 
recording platforms 
• Test the effect of acute and chronic blocking or stimulation at a stage of established 
disease  
o Study the effect on established disease to get a more reliable, early 
indication of therapeutic feasibility   
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o Test partial/intermittent as well as full signal blocking and stimulation; as 
interfaces and stimulation equipment advance, test the effect of introducing 
more naturalistic patterns of neural activity   
• Seek rapid read-outs across visceral organs and functions, whilst sharing findings 
with the community 
o Sample widely across key visceral organs as experimental procedures can 
be standardized, streamlined and rapidly conducted 
o Share experimental approaches to, for example, surgical nerve access, sham 
controls and correlation analysis through publications and workshops 
o Focus on proving the principle of nerve intervention, using available data on 
neurotransmitter agonist/antagonist and direct organ stimulation to inform the 





Identify specific neural patterns for targeted effects in disease in a set of model organs. 
 
Research imperatives: 
• Establish optimal points for modulation of the disease-associated function in a 
focused set of model organs 
o Focus efforts on a smaller set of organs with clear neural control: 
parasympathetic (lungs, heart), sympathetic (spleen61, adrenal gland), and 
afferent (carotid sinus, bladder) 
o Use the anatomical mapping and functional decoding to identify putative 
points for intervention – near the organ on small nerve branches or farther 
from the organ on the mixed, pre-ganglionic bundles of nerves  
o Compare the effect of stimulation/blocking on different nodal points, utilising 
interface arrays to gain functionally-specific effect in multi-function bundles  
• Create the equivalent of dose-response curves in the multi-dimensional space of 
neural signalling patterns 
o Use the neural code, that is, the recorded signalling patterns, as a starting 
point for stimulation and blocking parameters 
o Seek to apply both block and stimulation at the resolution of functional units 
o Explore the effect of changes to both average variables (for example, 
frequencies, compound amplitudes) and temporal patterns (for example, 
spike bursts)   
o Use response variables that are on a similar timescale as the neural 
signalling patterns, including intermediary/surrogate biomarkers   
• Test the efficacy and side-effect profile of closed-loop control in response to 
o Underlying neural signals that correlate with disease  
o Neural recording of signal change resulting from stimulation/blocking 
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• Expand the set of electrochemical, electrophysiological, and immunohistochemical 
tools for evaluating the effect of chronic electrode implantation on visceral peripheral 
nerves52,54 
• Examine the immune reaction at visceral nerves when interfacing with different 
architectures and materials 
o Use immunohistochemistry to understand the immune reaction to neural 
interfacing over time   
o Conduct within-animal biocompatibility comparisons of surface materials, and 
establish the degree of scar tissue formation in response to implantation 
o Explore differences across model species given differences in rodent and 
human immune systems 
• Determine the extent of neurological damage and plasticity (anatomical and 
physiological) in response to chronic neuromodulation 
o Quantify changes to neural impedance, spontaneous activity, and conduction 
parameters over time in response to chronic stimulation/blocking62 
o Use imaging and high-resolution anatomical mapping to determine whether 
axonal numbers and morphology change over time upon chronic stimulation 
or blocking (for example, axonal loss)52,53,63,64 
o Establish if neural signals upon physiological perturbations change over time 
• Map long-term adaptations to neuromodulation across connected organs and 
functions  
o Map any compensatory neural and physiological changes that may lead to 
resistance of therapy 
o Assess potential changes both locally in the targeted organ and distally in 
other organs and functions in the same system (for example, hemodynamics 
and metabolism); where multi-organ systems are affected, ensure animal 
models are representative of the human system and its pathology                
o Explore whether systemic changes can be modulated for better treatment 
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